
Redentor M. Pasia
Examiner (ID: 12532, Phone: (571)272-9745 , Office: P/2479 )
| Most Active Art Unit | 2413 |
| Art Unit(s) | 2474, 2616, 2413, 2479, 2416 |
| Total Applications | 766 |
| Issued Applications | 559 |
| Pending Applications | 77 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5880571
[patent_doc_number] => 20060029653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Therapeutic delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/241278
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9001
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11241278
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/241278 | Therapeutic delivery system | Sep 29, 2005 | Abandoned |
Array
(
[id] => 5808389
[patent_doc_number] => 20060094744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Pharmaceutical dosage forms of stable amorphous rapamycin like compounds'
[patent_app_type] => utility
[patent_app_number] => 11/237301
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7686
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11237301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/237301 | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds | Sep 27, 2005 | Abandoned |
Array
(
[id] => 5168758
[patent_doc_number] => 20070069189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Ultraviolet absorber and its use'
[patent_app_type] => utility
[patent_app_number] => 11/235179
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4443
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20070069189.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235179 | Ultraviolet absorber and its use | Sep 26, 2005 | Abandoned |
Array
(
[id] => 4697885
[patent_doc_number] => 20080220069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Long Acting Injectable Crystal Formulations of Estradiol Metabolites and Methods of Using Same'
[patent_app_type] => utility
[patent_app_number] => 11/663003
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6147
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20080220069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663003 | Long Acting Injectable Crystal Formulations of Estradiol Metabolites and Methods of Using Same | Sep 12, 2005 | Abandoned |
Array
(
[id] => 5182600
[patent_doc_number] => 20070053946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Hydrophilic coating'
[patent_app_type] => utility
[patent_app_number] => 11/220159
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1670
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11220159
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/220159 | Hydrophilic coating | Sep 5, 2005 | Issued |
Array
(
[id] => 5715254
[patent_doc_number] => 20060078617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Pharmaceutical compositions for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/212907
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4385
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212907 | Pharmaceutical compositions for the treatment of cancer | Aug 28, 2005 | Abandoned |
Array
(
[id] => 5148284
[patent_doc_number] => 20070048343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Biocidal premixtures'
[patent_app_type] => utility
[patent_app_number] => 11/212341
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5012
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212341 | Biocidal premixtures | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5716098
[patent_doc_number] => 20060079461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Treatment of multiple myeloma by inhibition of p38 MAP kinase'
[patent_app_type] => utility
[patent_app_number] => 11/207542
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11134
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207542 | Treatment of multiple myeloma by inhibition of p38 MAP kinase | Aug 18, 2005 | Abandoned |
Array
(
[id] => 5727535
[patent_doc_number] => 20060058296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase'
[patent_app_type] => utility
[patent_app_number] => 11/208481
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10983
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058296.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208481
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208481 | Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase | Aug 18, 2005 | Abandoned |
Array
(
[id] => 4720
[patent_doc_number] => 07812051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Pharmaceutical compositions of β-lapachone and β-lapachone analogs with improved tumor targeting potential'
[patent_app_type] => utility
[patent_app_number] => 11/201097
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 37876
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812051.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201097 | Pharmaceutical compositions of β-lapachone and β-lapachone analogs with improved tumor targeting potential | Aug 10, 2005 | Issued |
Array
(
[id] => 6977370
[patent_doc_number] => 20050287086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Tooth whitening products'
[patent_app_type] => utility
[patent_app_number] => 11/199976
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10345
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287086.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199976 | Tooth whitening products | Aug 8, 2005 | Abandoned |
Array
(
[id] => 190976
[patent_doc_number] => 07642287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Statin pharmaceutical compositions and related methods of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/197880
[patent_app_country] => US
[patent_app_date] => 2005-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 18379
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11197880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/197880 | Statin pharmaceutical compositions and related methods of treatment | Aug 4, 2005 | Issued |
Array
(
[id] => 5799159
[patent_doc_number] => 20060034782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Biofilm therapy interproximal devices'
[patent_app_type] => utility
[patent_app_number] => 11/196827
[patent_app_country] => US
[patent_app_date] => 2005-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 15312
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11196827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/196827 | Biofilm therapy interproximal devices | Aug 2, 2005 | Abandoned |
Array
(
[id] => 5601747
[patent_doc_number] => 20060292092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Oral care compositions, devices, and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/195448
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4951
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11195448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/195448 | Oral care compositions, devices, and methods of using the same | Jul 31, 2005 | Abandoned |
Array
(
[id] => 7693853
[patent_doc_number] => 20070015833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Formulations of fenofibrate containing menthol'
[patent_app_type] => utility
[patent_app_number] => 11/182777
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7187
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015833.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182777 | Formulations of fenofibrate containing menthol | Jul 17, 2005 | Abandoned |
Array
(
[id] => 7046106
[patent_doc_number] => 20050250701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Method of treating the syndrome of coronary heart disease risk factors in humans'
[patent_app_type] => utility
[patent_app_number] => 11/183059
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6042
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250701.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183059 | Method of treating the syndrome of coronary heart disease risk factors in humans | Jul 14, 2005 | Abandoned |
Array
(
[id] => 5074765
[patent_doc_number] => 20070014740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Oral compositions having cationic active ingredients'
[patent_app_type] => utility
[patent_app_number] => 11/182398
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8858
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11182398
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/182398 | Oral compositions having cationic active ingredients | Jul 14, 2005 | Abandoned |
Array
(
[id] => 7045085
[patent_doc_number] => 20050249680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Structures and compositions increasing the stability of peroxide actives'
[patent_app_type] => utility
[patent_app_number] => 11/181329
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9067
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181329
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181329 | Structures and compositions increasing the stability of peroxide actives | Jul 13, 2005 | Abandoned |
Array
(
[id] => 5842310
[patent_doc_number] => 20060121073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Topical gel formulation comprising insecticide and its preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/179924
[patent_app_country] => US
[patent_app_date] => 2005-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11387
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179924 | Topical gel formulation comprising insecticide and its preparation thereof | Jul 11, 2005 | Abandoned |
Array
(
[id] => 5738151
[patent_doc_number] => 20060008541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Sodium channel agonist'
[patent_app_type] => utility
[patent_app_number] => 11/177260
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177260 | Sodium channel agonist | Jul 7, 2005 | Abandoned |